Search

everythinglearnresearchcommunity

for

Search:↓

Post-finasteride syndrome's existence is uncertain; more research needed.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Minoxidil in breast milk may harm nursing infants.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Finasteride works better than Permixon in reducing dihydrotestosterone levels.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Lespedeza cuneata extract may help treat enlarged prostate.

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.